Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings
About Vcanbio Cell & Gene Engineering Corp., Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | |
| 独立董事候选人声明与承诺(张业炎) | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司2025年年度报告 | 2026-04-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41331938 | 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | ||
| 41331932 | 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | ||
| 41331925 | 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | ||
| 41331911 | 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | ||
| 41331904 | 独立董事候选人声明与承诺(张业炎) | 2026-04-24 | Chinese | ||
| 41331902 | 中源协和细胞基因工程股份有限公司2025年年度报告 | 2026-04-24 | Chinese | ||
| 41331900 | 中源协和细胞基因工程股份有限公司关于会计政策变更的公告 | 2026-04-24 | Chinese | ||
| 41331895 | 中源协和细胞基因工程股份有限公司重大风险和突发事件预警与应急处理制度 | 2026-04-24 | Chinese | ||
| 41331885 | 中源协和细胞基因工程股份有限公司内幕信息知情人管理制度 | 2026-04-24 | Chinese | ||
| 41331876 | 中源协和细胞基因工程股份有限公司关于计提资产减值损失的公告 | 2026-04-24 | Chinese | ||
| 41331863 | 中源协和细胞基因工程股份有限公司审计报告 | 2026-04-24 | Chinese | ||
| 41330857 | 中源协和细胞基因工程股份有限公司防范控股股东、实际控制人及其他关联方占用资金管理制度 | 2026-04-24 | Chinese | ||
| 41330846 | 中源协和细胞基因工程股份有限公司对会计师事务所履职情况的评估报告 | 2026-04-24 | Chinese | ||
| 41330844 | 中源协和细胞基因工程股份有限公司2025年度独立董事述职报告(罗明生) | 2026-04-24 | Chinese | ||
| 41330834 | 中源协和细胞基因工程股份有限公司自愿信息披露管理制度 | 2026-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Vcanbio Cell & Gene Engineering Corp., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56891/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56891 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56891 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56891 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56891}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vcanbio Cell & Gene Engineering Corp., Ltd (id: 56891)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.